David Loach
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments
Papers in ⓘ
- Hematology 25
- Hematopoietic Stem Cell Transplantation 22
- Acute Myeloid Leukemia Research 15
- Chronic Myeloid Leukemia Treatments 4
- Genetics 10
- Mesenchymal stem cell research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Co-authors
- Jeffrey H. Lipton (27 shared papers)Fotios V. Michelis (23 shared papers)Hans A. Messner (16 shared papers)Vikas Gupta (13 shared papers)John Kuruvilla (12 shared papers)Eshetu G. Atenafu (9 shared papers)Auro Viswabandya (15 shared papers)Rajat Kumar (11 shared papers)
- Journals
- Biology of Blood and Marrow Transplantation (7 papers)Bone Marrow Transplantation (6 papers)Blood (6 papers)European Journal Of Haematology (5 papers)Hematology/Oncology and Stem Cell Therapy (1 paper)
- Partner nations
- CanadaSouth KoreaNew Zealand
In The Last Decade
David Loach
26 papers receiving 350 citations
Peers
Comparison fields: 5 of 43
- Hematology 297
- Transplantation 34
- Genetics 83
- Oncology 87
- Immunology 62
Countries citing papers authored by David Loach
This map shows the geographic impact of David Loach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Loach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Loach more than expected).
Fields of papers citing papers by David Loach
This network shows the impact of papers produced by David Loach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Loach. The network helps show where David Loach may publish in the future.
Co-authors
The 25 scholars most cited alongside David Loach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 60 | |
| 2 | 2020 | 40 | |
| 3 | 2019 | 31 | |
| 4 | 2016 | 25 | |
| 5 | 2015 | 23 | |
| 6 | 1997 | 22 | |
| 7 | 2013 | 21 | |
| 8 | 2019 | 19 | |
| 9 | 2019 | 18 | |
| 10 | 2019 | 17 | |
| 11 | 2014 | 14 | |
| 12 | 2013 | 13 | |
| 13 | 2019 | 10 | |
| 14 | 2017 | 8 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 4 | |
| 18 | 2007 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2019 | 2 |
About David Loach
David Loach is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Transplantation, having authored 28 papers that have together received 350 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (22 papers), Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Renal Transplantation Outcomes and Treatments (4 papers), Mesenchymal stem cell research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Hematology (297 citations), Transplantation (34 citations), Genetics (83 citations), Oncology (87 citations) and Immunology (62 citations). David Loach has collaborated with scholars based in Canada, South Korea and New Zealand. Frequent co-authors include Jeffrey H. Lipton, Fotios V. Michelis, Hans A. Messner, Vikas Gupta, John Kuruvilla, Eshetu G. Atenafu, Auro Viswabandya, Rajat Kumar, Arjun Law and Zeyad Al‐Shaibani. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, Blood, European Journal Of Haematology and Hematology/Oncology and Stem Cell Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.